Inhibikase Therapeutics, Inc. - Common Stock (IKT)

1.6750
+0.0050 (0.30%)
NASDAQ· Last Trade: Jun 16th, 10:50 AM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors